Image

Efficacy of a Very Low Calories Ketogenic Diet in Obese Patients With Fibromyalgia or Symptomatic Knee Osteoarthritis

Recruiting
18 - 65 years of age
Both
Phase N/A

Powered by AI

Overview

Adult patients with fibromyalgia or symptomatic knee osteoarthritis and comorbid obesity eligible to a very low calories ketogenic diet will be enrolled in the pilot study

Description

the study will be conducted following different periods:

  1. Free diet (for 4 weeks). After recruitment, the patient will enter "free diet phase" in which he/she will be asked to follow a normal free diet for 4 weeks. During this period, a nutritional interview will be carried out by a trained dietician who will elaborate a personalized diet and order the ketogenic products on the basis of patient's preferences.
  2. very low calories ketogenic diet (for 8 weeks). After the free diet period, the patient will start the very low calories ketogenic regimen. At the beginning of this period a box with the commercial products necessary to cover the whole study period will be hand-delivered by a dietician that will instruct the patient on the correct use and storage.
  3. Maintenance (for 12 weeks). After very low calories ketogenic diet phase, the patient will start maintenance period as described

Eligibility

Inclusion Criteria:

  • Age > 18 years and < 65 years
  • Body mass index ≥ 30 kg/m2
  • Failed to achieve weight loss with standard low-calories diet
  • Any of the following conditions:
        BMI ≥ 35 kg/m2 Past diagnosis of type 2 diabetes without β-cell failure
        Hypertriglyceridemia (fasting triglycerides ≥ 150 mg/dL) or taking lipid-lowering
        medications Hypercholesterolemia (total cholesterol > 200 mg/dL) or taking lipid-lowering
        medications Past diagnosis of arterial hypertension or taking blood pressure-lowering
        medications Past diagnosis of non-alcoholic fatty liver disease Past diagnosis of heart
        failure class NYHA I-II Past history of myocardial infarction (> 12 months), stroke/minor
        stroke (> 12 months) Past diagnosis of carotid atherosclerosis Past diagnosis of polycystic
        ovary syndrome (PCOS) Past diagnosis of neurodegenerative disorders
          -  Fibromyalgia classified according to 2016 Revisions to the 2010/2011 European League
             Against Rheumatism/ American College of Rheumatology OR
          -  Symptomatic knee osteoarthritis
        Exclusion Criteria:
          -  Age < 18 or > 65 years
          -  Currently pregnant or breastfeeding
          -  Past diagnosis of type 1 diabetes mellitus, latent autoimmune diabetes in adults,
             β-cell failure in type 2 diabetes mellitus, use of sodium/glucose cotransporter 2
             inhibitors (risk for euglycemic diabetic ketoacidosis)
          -  Past diagnosis of kidney failure and moderate-to-severe chronic kidney disease, liver
             failure, hearth failure NYHA III-IV, respiratory failure
          -  Past diagnosis of unstable angina
          -  Recent stroke or myocardial infarction (< 12 months)
          -  Cardiac arrhythmias
          -  Past diagnosis of eating disorders and other severe mental illnesses, alcohol and
             substance abuse
          -  Active/severe infections
          -  48 h prior to elective surgery or invasive procedures and perioperative period
          -  Past diagnosis of rare disorders: porphyria, carnitine deficiency, carnitine
             palmitoyltransferase deficiency, carnitine-acylcarnitine translocase deficiency,
             mitochondrial fatty acid β-oxidation disorders, pyruvate carboxylase deficiency
          -  Allergy to protein-preparations ingredients
          -  Past or current history of gallstones

Study details

Fibromyalgia, Knee Osteoarthritis

NCT05848544

Istituto Ortopedico Rizzoli

8 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.